Professional medical writing support

Good publication practice for pharmaceutical companies

DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, Hanekamp E, Dormer L, DiBiasi F, Bridges D, Baltzer L, Citrome L. Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Ann Intern Med. 2022. PMID: 36037471
GPP2022 replaces GPP3 [Battisti et al. 2015; PMID: 26259067], GPP2 [Graf et al. 2009; PMID: 19946142] and GPP [Wager et al. 2003; PMID: 12814125]

A resource guide to best practices in the preparation and submission of manuscripts describing industry-sponsored research prepared by the Medical Publishing Insights and Practices Initiative (MPIP)
Reporting adverse events in clinical trial publications developed by Medical Publishing Insights and Practices (MPIP), the International Society for Medical Publication Professionals and representatives from the pharmaceutical industry
Chipperfield L, Citrome L, Clark J, David FS, Enck R, Evangelista M, Gonzalez J, Groves T, Magrann J, Mansi B, Miller C, Mooney LA, Murphy A, Shelton J, Walson PD, Weigel A. Authors’ submission toolkit: A practical guide to getting your research published. CMRO. 2010;26(8):1967-1982. PMID: 20569069

Marušic A, Hren D, Mansi B, Lineberry N, Bhattacharya A, Garrity M, et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med. 2014;12:197. PMID: 25604352

International Society for Medical Publication Professionals (ISMPP) Code of Ethics
Joint statement on the role of medical writers (PDF) from the American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA), and the International Society for Medical Publication Professionals (ISMPP), explicitly mentioning reporting guidelines and EQUATOR Network, issued January 2017
American Medical Writers Association; European Medical Writers Association; International Society for Medical Publication Professionals. AMWA-EMWA-ISMPP joint position statement on medical publications, preprints, and peer review. Curr Med Res Opin. 2021:1-6. PMID: 33789058

Gotzsche PC, Kassirer JP, Woolley KL, Wager E, Jacobs A, et al. What Should Be Done To Tackle Ghostwriting in the Medical Literature? PLoS Med 2009;6(2): e1000023 doi:10.1371/journal.pmed.1000023; contains a checklist for authors using medical writers
Matcham J, Julious S, Pyke S, O’Kelly M, Todd S, Seldrup J, Day S. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharm Stat. 2011;10(1):70-73. PMID: 20187020
Webinar series produced by MedComms Networking – practical talks and tips for medical writers (MedComms Networking YouTube channel)